{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:54:12Z","timestamp":1782996852842,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013704","name":"Consejo Nacional de Ciencia y Tecnolog\u00c3\u00ada, Paraguay","doi-asserted-by":"publisher","award":["M-43604"],"award-info":[{"award-number":["M-43604"]}],"id":[{"id":"10.13039\/501100013704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ejphar.2007.06.034","type":"journal-article","created":{"date-parts":[[2007,6,30]],"date-time":"2007-06-30T07:13:01Z","timestamp":1183187581000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat"],"prefix":"10.1016","volume":"573","author":[{"given":"Nadia L.","family":"Caram-Salas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Reyes-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd D.","family":"Bartoszyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia I.","family":"Araiza-Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Ambriz-Tututi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor I.","family":"Rocha-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaura","family":"Arreola-Espino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia L.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicio","family":"Granados-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.06.034_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1476-5381.1994.tb17142.x","article-title":"A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753","volume":"113","author":"Barber","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/13543784.6.10.1351","article-title":"Novel developments with selective, non-peptidic kappa-opioid receptor agonists","volume":"6","author":"Barber","year":"1997","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2007.06.034_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/1064-1297.14.1.1","article-title":"Low efficacy opioids: implications for sex differences in opioid antinociception","volume":"14","author":"Barrett","year":"2006","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(02)02274-4","article-title":"Sex-related differences in mechanical nociception and antinociception produced by mu-and kappa-opioid receptor agonists in rats","volume":"452","author":"Barrett","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2004.04.043","article-title":"Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats","volume":"494","author":"Bileviciute-Ljungar","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.bjp.0701874","article-title":"Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis","volume":"124","author":"Binder","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3565(24)35292-9","article-title":"Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids","volume":"292","author":"Binder","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.06.034_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-2999(98)00597-4","article-title":"Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats","volume":"357","author":"Catheline","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2007.06.034_bib10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000542-200312000-00026","article-title":"Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats","volume":"99","author":"Chen","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2007.06.034_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(00)00209-X","article-title":"Sex differences in opioid antinociception: kappa and \u2018mixed action\u2019 agonists","volume":"63","author":"Craft","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2007.06.034_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2036.2004.01922.x","article-title":"Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome","volume":"20","author":"Delvaux","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.06.034_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0304-3959(98)00177-8","article-title":"The kappa opioid agonist GR89,696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy","volume":"79","author":"Eliav","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2007.06.034_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1431","article-title":"State-dependent opioid control of pain","volume":"5","author":"Fields","year":"2004","journal-title":"Nat. Rev."},{"key":"10.1016\/j.ejphar.2007.06.034_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","article-title":"Neurotransmitters in nociceptive modulatory circuits","volume":"14","author":"Fields","year":"1991","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.034_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0304-3959(98)00237-1","article-title":"Enadoline, a selective kappa-opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain","volume":"80","author":"Field","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2007.06.034_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/chir.530060814","article-title":"Kappa-opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753","volume":"6","author":"Gottschlich","year":"1994","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2007.06.034_bib18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/00001756-199806010-00019","article-title":"Mu and kappa opioid receptors in periaqueductal grey and rostral ventromedial medulla","volume":"9","author":"Gutstein","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2007.06.034_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(97)00221-2","article-title":"Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists","volume":"75","author":"Hao","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2007.06.034_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1523\/JNEUROSCI.07-01-00271.1987","article-title":"Evidence for two classes of nociceptive modulating neurons in the periaqueductal grey","volume":"7","author":"Heinricher","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.034_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pbb.2005.12.013","article-title":"Characterization of the antinociceptive effect of oxycodone in male and female rats","volume":"83","author":"Holtman","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.06.034_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1358\/dof.1988.013.12.77462","article-title":"Kappa opioid analgesics","volume":"13","author":"Horwell","year":"1988","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejphar.2007.06.034_bib23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1517\/13543776.14.12.1725","article-title":"Kappa-opioid receptor ligands","volume":"14","author":"Husbands","year":"2004","journal-title":"Expert Opinion Ther. Pat."},{"key":"10.1016\/j.ejphar.2007.06.034_bib24","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1007\/s00125-006-0397-y","article-title":"Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats","volume":"49","author":"Jolivalt","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2007.06.034_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/jpet.103.049023","article-title":"Nonopioid actions of U50,488 enantiomers contribute to their peripheral cutaneous antinociceptive effects","volume":"305","author":"Joshi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.06.034_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(95)00122-2","article-title":"Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood\u2013brain barrier (ICI 204448) in a rat model of mononeuropathy","volume":"277","author":"Ke\u00efta","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2007.06.034_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2005.02.049","article-title":"Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib","volume":"513","author":"Lozano-Cuenca","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0022-3565(24)34907-9","article-title":"Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans","volume":"290","author":"Machelska","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.06.034_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0306-4522(95)00464-5","article-title":"Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary","volume":"71","author":"Mansour","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.06.034_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1254\/fpj.123.95","article-title":"Molecular pharmacology of opioid receptors","volume":"123","author":"Minami","year":"2004","journal-title":"Nippon Yakurigaku Zasshi."},{"key":"10.1016\/j.ejphar.2007.06.034_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0169-328X(94)00290-U","article-title":"Double in situ hybridization study on coexistence of mu-, delta-and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia","volume":"30","author":"Minami","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.034_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(86)91367-3","article-title":"Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission","volume":"397","author":"Moreau","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.034_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jcp.20693","article-title":"Neurobiology of pain","volume":"209","author":"Pace","year":"2006","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib36","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2007.06.034_bib37","series-title":"Descending Inhibitory Systems","first-page":"179","volume":"vol. 81","author":"Pertovaara","year":"2006"},{"key":"10.1016\/j.ejphar.2007.06.034_bib38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-2007-1012453","article-title":"Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man","volume":"18","author":"Pfeiffer","year":"1986","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2007.06.034_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0166-2236(02)02157-4","article-title":"Chronic pain and medullary descending facilitation","volume":"25","author":"Porreca","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.034_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(00)02481-1","article-title":"Basal and cocaine-induced opioid receptor gene expression in the rat CNS analyzed by competitive reverse transcription PCR","volume":"28","author":"Rosin","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.06.034_bib41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.94.305","article-title":"Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice","volume":"94","author":"Sounvoravong","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2007.06.034_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpain.2004.12.006","article-title":"Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats","volume":"6","author":"Stoffel","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2007.06.034_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(00)01394-X","article-title":"Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury","volume":"291","author":"Sung","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.06.034_bib44","first-page":"362","article-title":"Cellular actions of opioids on periaqueductal grey neurons from C57B16\/J mice and mutant mice lacking MOR-1.Br","volume":"139","author":"Vaughan","year":"2003","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.06.034_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0304-3959(99)00158-X","article-title":"Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats","volume":"83","author":"Walker","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2007.06.034_bib47","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1523\/JNEUROSCI.5552-03.2004","article-title":"Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance","volume":"24","author":"Xu","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.06.034_bib48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1399-6576.1997.tb04623.x","article-title":"Pharmacology and mechanisms of opioid analgesic activity","volume":"41","author":"Yaksh","year":"1997","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejphar.2007.06.034_bib49","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2007.06.034_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guides for investigations on experimental pain in conscious animals","volume":"16","author":"Zimmerman","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907007455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907007455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:09:01Z","timestamp":1757974141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907007455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0014299907007455"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.06.034","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}